The specialty’s leading advocate, the Advocacy Council, is committed to bringing you news and insights on billing, coding and policy reform that directly affect your practice. Advocacy Insider, a recurring column in College Insider, keeps you in the loop.
Contact us at AdvocacyCouncil@acaai.org or 847-427-1200.
- Show all
- A/I Action
- Advocacy Alert
- Advocacy Resources
- AllergyWatch
- Annals
- Annual Meeting
- CA2PER Program
- College Advantage
- Committees
- Course
- COVID-19
- Disaster Resources
- Education
- Event
- Foundation
- From College Leadership
- Gold Headed Cane
- History
- House of Delegates
- Member benefit
- New Allergists
- News
- Opinion
- Pathways to Practice
- Patient Brochures
- Payer Education Campaign
- Resources
- Survey
- Time For An Allergist
- Uncategorized
- Webinar
Issue with federal BCBS coverage of Xolair for IgE-mediated food allergy
Reports from members indicate that the FEP is denying coverage for Xolair unless the patient demonstrates confirmed allergies to peanuts plus at least two othe…
Food allergy testing guidance and coding
The cornerstone of effective food allergy diagnosis is a thorough clinical history.
Medicare denials for immunotherapy injections with venom immunotherapy
This issue began appearing last fall, affecting multiple Medicare Administrative Contractors (MACs). Denials typically cite reason code CO-50.
Congress passes ACAAI-backed Protecting Children with Food Allergies Act
This legislation represents an important step toward improving the safety and well-being of students with food allergies across the country.
2027 Medicare price reductions for asthma inhalers
CMS unveiled agreements with drug makers for sharply lower prices on 15 high-cost medications under Medicare's drug negotiation program.
College OIT Coding Recommendations
Always verify individual payer policies in writing before initiating OIT services, as coverage and accepted codes vary widely.
2026 MIPS Final Policies
CMS has finalized its proposal to maintain the 75-point performance threshold through the 2028 performance period.
Understanding the 2026 Medicare Physician Fee Schedule Final Rule
This article outlines important payment and policy changes that will shape reimbursement and practice operations for allergists in the coming year.
Adhering to USP 797 standards for in-office extract preparation
Compounding guidelines ensure patient safety by minimizing contamination, incorrect dosing, or other errors during sterile preparation.
Defend the allergy specialty
Our need to defend the allergy specialty is critical! These issues threaten our practices, specialty, and livelihoods.
